ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

Post Starts Series With Horror Stories On Drug Testing; DeVita Says They Are “Slanted, Distorted”

October 23, 1981

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

In Brief: George Burton Retires After 23 Years At NCI; MDA Names Bodey Head Of Medical Specialists

February 20, 1987

Definitions, New Categories Of Centers Suggested By Cantril

July 2, 1976